HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daiming Fan Selected Research

Etoposide (VP 16)

1/2020EI24 Inhibits Cell Proliferation and Drug Resistance of Esophageal Squamous Cell Carcinoma.
4/2016miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
8/2006TRF2 promotes multidrug resistance in gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daiming Fan Research Topics

Disease

184Neoplasms (Cancer)
04/2024 - 01/2002
167Stomach Neoplasms (Stomach Cancer)
03/2024 - 01/2002
74Neoplasm Metastasis (Metastasis)
02/2024 - 03/2004
42Hepatocellular Carcinoma (Hepatoma)
02/2024 - 03/2006
34Carcinogenesis
03/2023 - 08/2002
30Hemorrhage
10/2023 - 01/2011
28Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 06/2008
27Fibrosis (Cirrhosis)
10/2023 - 01/2011
24Thrombosis (Thrombus)
12/2023 - 02/2010
16Hepatic Encephalopathy
01/2022 - 06/2010
16Hypoxia (Hypoxemia)
11/2019 - 08/2004
15Carcinoma (Carcinomatosis)
12/2011 - 04/2002
13Ascites
09/2023 - 01/2011
12Liver Cirrhosis (Hepatic Cirrhosis)
12/2023 - 08/2007
12Portal Hypertension
01/2023 - 11/2010
10Colonic Neoplasms (Colon Cancer)
01/2019 - 06/2008
10Adenocarcinoma
12/2016 - 06/2004
8Budd-Chiari Syndrome (Budd Chiari Syndrome)
01/2019 - 03/2013
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2008
7Inflammation (Inflammations)
10/2023 - 01/2009
6Esophageal Neoplasms (Esophageal Cancer)
01/2019 - 06/2010
6Liver Diseases (Liver Disease)
01/2019 - 12/2013
6Infections
01/2017 - 08/2008
6Lymphatic Metastasis
07/2016 - 02/2008
4Liver Neoplasms (Liver Cancer)
01/2018 - 12/2013
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2017 - 10/2011
4Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2017 - 06/2007
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
3Gastritis
01/2022 - 01/2005
3Non-alcoholic Fatty Liver Disease
10/2020 - 05/2010

Drug/Important Bio-Agent (IBA)

83Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2002
45MicroRNAs (MicroRNA)IBA
10/2023 - 07/2008
31Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2010
30Small Interfering RNA (siRNA)IBA
08/2014 - 06/2004
21Messenger RNA (mRNA)IBA
01/2023 - 04/2002
16Doxorubicin (Adriamycin)FDA LinkGeneric
06/2015 - 07/2002
15Vincristine (Oncovin)FDA LinkGeneric
06/2015 - 07/2002
13Monoclonal AntibodiesIBA
12/2022 - 01/2005
13AntigensIBA
11/2017 - 02/2005
12CytokinesIBA
03/2023 - 01/2002
11Peptides (Polypeptides)IBA
12/2012 - 02/2005
10LigandsIBA
07/2023 - 03/2006
10Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2012
9RNA (Ribonucleic Acid)IBA
01/2023 - 08/2008
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 04/2006
9Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2010 - 08/2002
8Long Noncoding RNAIBA
01/2023 - 01/2014
8Carrier Proteins (Binding Protein)IBA
12/2022 - 09/2002
8Sorafenib (BAY 43-9006)FDA Link
10/2020 - 08/2012
8Prion ProteinsIBA
09/2017 - 01/2005
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2013 - 01/2002
8Member 1 Subfamily B ATP Binding Cassette TransporterIBA
06/2010 - 04/2004
7multidrug resistance-associated protein 1IBA
08/2013 - 08/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 08/2004
7beta CateninIBA
10/2011 - 03/2006
7Cyclin D1IBA
06/2010 - 01/2002
6Indicators and Reagents (Reagents)IBA
01/2023 - 09/2007
6Cetuximab (Erbitux)FDA Link
12/2022 - 11/2016
6alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2017 - 07/2009
6AgarIBA
06/2017 - 08/2004
6EpitopesIBA
05/2013 - 02/2005
6S100 Calcium Binding Protein A6IBA
10/2011 - 09/2002
5Cadherins (E-Cadherin)IBA
01/2019 - 06/2007
5VaccinesIBA
01/2014 - 03/2002
4BerberineIBA
01/2024 - 11/2016
4LuciferasesIBA
11/2021 - 05/2007
4BilirubinIBA
06/2020 - 09/2014
4Carcinoembryonic AntigenIBA
11/2017 - 12/2011
4human MGr1-antigenIBA
09/2017 - 01/2002
4Interleukin-6 (Interleukin 6)IBA
01/2017 - 01/2002
4Interleukin-8 (Interleukin 8)IBA
10/2015 - 01/2002
4GTP Phosphohydrolases (GTPases)IBA
08/2014 - 08/2004
4SurvivinIBA
10/2013 - 04/2008
4Complementary DNA (cDNA)IBA
02/2013 - 06/2008
4OsteopontinIBA
11/2012 - 02/2007
4hepatitis B virus X proteinIBA
09/2012 - 05/2007
4Ribosomal Proteins (Ribosomal Protein)IBA
02/2011 - 06/2004
4Proteasome InhibitorsIBA
07/2010 - 04/2008
4Phosphotransferases (Kinase)IBA
02/2010 - 10/2005
4Cisplatin (Platino)FDA LinkGeneric
09/2009 - 07/2002
4ZincIBA
08/2007 - 04/2004
3N-methyladenosineIBA
03/2024 - 12/2022
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2023 - 08/2010
3AntibodiesIBA
01/2023 - 01/2015
3ChromatinIBA
01/2023 - 02/2013
36-methyladenineIBA
01/2023 - 12/2022
3Prothrombin (Factor II)IBA
07/2020 - 11/2014
3factor V LeidenIBA
07/2020 - 10/2011
3Monomeric GTP-Binding ProteinsIBA
01/2020 - 08/2004
3Etoposide (VP 16)FDA LinkGeneric
01/2020 - 08/2006
3InterleukinsIBA
01/2020 - 10/2015

Therapy/Procedure

71Therapeutics
03/2024 - 02/2005
36Transjugular Intrahepatic Portasystemic Shunt
12/2023 - 11/2010
34Drug Therapy (Chemotherapy)
03/2024 - 01/2004
34Surgical Portasystemic Shunt (Portosystemic Shunt)
10/2023 - 02/2010
14Stents
01/2022 - 11/2010
10Immunotherapy
04/2024 - 01/2002
6Gastrectomy
11/2017 - 01/2014
4Transplantation
01/2019 - 07/2008
4Fecal Microbiota Transplantation
10/2017 - 01/2015